hepatoblastoma malignant liver cancer occurring infants children composed tissue resembling fetal liver cells mature liver cells bile duct cells usually present abdominal mass disease commonly diagnosed childs first three years alphafetoprotein afp levels commonly elevated afp elevated diagnosis prognosis patients usually asymptomatic result disease often advanced diagnosis hepatoblastomas originate immature liver precursor cells typically unifocal affect right lobe liver often left lobe metastasize categorized two types epithelial type mixed epithelial mesenchymal typecitation needed individuals familial adenomatous polyposis fap syndrome earlyonset colonic polyps adenocarcinoma frequently develop also betacatenin mutations shown common sporadic hepatoblastomas occurring many recently components wnt signaling pathway also demonstrated likely role constitutive activation pathway causation accumulating evidence suggests hepatoblastoma derived pluripotent stem syndromes increased incidence hepatoblastoma include syndrome trisomy trisomy acardi syndrome syndrome goldenhar syndrome von gierke disease familial adenomatous common method testing hepatoblastoma blood test checking alphafetoprotein level alphafetoprotein afp used biomarker help determine presence liver cancer children birth infants relatively high levels afp fall normal adult levels second year life normal level afp children reported lower nanograms per milliliter ngml ngml adults afp level greater ngml significant indicator hepatoblastoma afp also used indicator treatment success treatments successful removing cancer afp level expected return surgical removal tumor neoadjuvant chemotherapy prior tumor removal liver transplantation used treat primary liver transplantation provides high long term diseasefree survival rate range cases complete tumor removal adjuvant chemotherapy survival rates approach presence metastases strongest predictor poor httpsenwikipediaorgwikihepatoblastoma